What is the current stock price of Aurinia Pharmaceuticals Inc. (AUPH)?

As of the latest market data, Aurinia Pharmaceuticals Inc. (AUPH) is trading at $15.76. The stock has seen a loss of -1.25% today.

Does Aurinia Pharmaceuticals Inc. (AUPH) pay a dividend?

Based on current data, Aurinia Pharmaceuticals Inc. does not have a confirmed active dividend policy.

What is the market cap of Aurinia Pharmaceuticals Inc.?

The current market capitalization of Aurinia Pharmaceuticals Inc. (AUPH) is approximately unavailable.

AUPH

Aurinia Pharmaceuticals Inc.·Healthcare

15.76

1.253%(−0.20)

Market Closed

16.50

4.695%(+0.74)

After Hours

Last Updated: — ET

52W L: $7.2952W H: $16.54

Company Profile

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.

Sector

Healthcare

Industry

Biotechnology

Employees

130

IPO Date

2014-09-03

Beta

1.52

Websitewww.auriniapharma.com↗